MMM
40
5
ABT
48
3
CPB
49
2
LEN
60
-7
PH
67
-4
FFIV
63
-3
WBA
38
3
KLAC
67
-4
DO
83
2
IVZ
62
-3
IP
65
3
BIIB
48
-3
STI
26
6
PHM
70
-4
EQIX
57
-2
PG
63
2
LLY
65
-3
CINF
54
3
TRV
49
4
BMY
33
-2
MMM
40
5
ABT
48
3
CPB
49
2
LEN
60
-7
PH
67
-4
FFIV
63
-3
WBA
38
3
KLAC
67
-4
DO
83
2
IVZ
62
-3
IP
65
3
BIIB
48
-3
STI
26
6
PHM
70
-4
EQIX
57
-2
PG
63
2
LLY
65
-3
CINF
54
3
TRV
49
4
BMY
33
-2
Financhill
Back

Janux Therapeutics Stock Predictions

Sell
37

JANX
Janux Therapeutics

Last Price:
47.32
Seasonality Move:
8.69%

7 Day Trial

ALL ACCESS PASS

$ 7

Janux Therapeutics Stock Forecast

  • Over the next 52 weeks, Janux Therapeutics has on average historically risen by 153.7% based on the past 2 years of stock performance.
  • Janux Therapeutics has risen higher in 2 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
  • Is Janux Therapeutics Stock Undervalued?
    The current Janux Therapeutics [JANX] share price is $47.51. The Score for JANX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Janux Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Janux Therapeutics has on average historically risen by 153.7% based on the past 2 years of stock performance.

Janux Therapeutics Stock Rating

Sell
37
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics overpriced?

  • Janux Therapeutics has risen higher in 2 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

Janux Therapeutics Stock Price History

Is JANX stock going to rise?

  • The current trend is moderately bearish and JANX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
januxrx.com

52-Week Data

52-Week High:
65.60
52-Week Low:
5.65

Prediction Charts

Market Cap:
2.46B
Price in USD:
47.51
Volume:
680.48K
Beta:
3.98

Technical Analysis

SMA50:
45.84
SMA100:
30.50
SMA200:
20.00
52-Wk Change:
312.06%

Stock Predictions

  • Is Janux Therapeutics stock public?
    Yes, Janux Therapeutics is a publicly traded company.
  • What is the Janux Therapeutics stock quote today?
    The Janux Therapeutics stock price is 47.51 USD today.
  • How to buy Janux Therapeutics stock online?
    You can buy Janux Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-29 47.85 56.08 61.00 47.58
Apr-30 54.88 57.09 57.11 53.60
May-1 57.00 58.19 60.05 55.53
May-2 59.94 62.43 64.79 56.41
May-3 63.98 64.78 65.60 59.31
May-6 63.16 62.19 63.34 57.11
May-7 62.67 61.44 63.37 60.39
May-8 53.68 55.37 58.00 51.63
May-9 54.00 52.00 54.91 50.79
May-10 52.92 48.92 53.54 48.54
May-13 50.00 50.00 50.08 47.92
May-14 50.90 47.91 51.33 47.51
May-15 49.22 47.48 49.87 47.34
May-16 47.18 47.51 48.25 46.57

Janux Therapeutics Earnings

Janux Therapeutics Earnings Report: Per Share Janux Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Janux Therapeutics Forecast Revenue Growth

Janux Therapeutics Stock Analysis: Historical quarterly revenues per share for Janux Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.05 per share, an increase this year of $0.09 per share, and a decrease next year of $0.57 per share.

* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.